Search results

1 – 3 of 3
Per page
102050
Citations:
Loading...
Available. Open Access. Open Access
Article
Publication date: 10 July 2018

Rita Ramayulis and Anhari Achadi

The purpose of this paper is to produce informative menu board media to show sugar, salt and fat (SSF) related health messages in a Senior High School canteen.

796

Abstract

Purpose

The purpose of this paper is to produce informative menu board media to show sugar, salt and fat (SSF) related health messages in a Senior High School canteen.

Design/methodology/approach

The research model included stages of needs analysis, design, product development and product evaluation. The data were collected from material experts, media experts and 186 high school students. Data were analyzed by descriptive qualitative and statistical analysis.

Findings

The C and D menu boards were selected for their content information and health messages that received higher scores.

Originality/value

There are four stages required in the development of menu board media: needs analysis, menu board design, product development and product evaluation. Further research would be needed to develop the menu boards into a simpler model.

Details

Journal of Health Research, vol. 32 no. 4
Type: Research Article
ISSN: 2586-940X

Keywords

Access Restricted. View access options
Article
Publication date: 31 May 2019

Ria Christine Siagian, Besral Besral, Anhari Achadi and Dumilah Ayuningtyas

The World Health Organization has pointed out that the majority of developing countries currently rely on imported drugs, in spite of the fact that there is potential for them to…

274

Abstract

Purpose

The World Health Organization has pointed out that the majority of developing countries currently rely on imported drugs, in spite of the fact that there is potential for them to produce their own drugs. The purpose of this paper is to present a framework as an innovation policy model that can strategically predict the outcome of drug development investment in developing countries.

Design/methodology/approach

In order to explore a model relevant to the policy-making process, the literature was systematically reviewed with a focus on the impact of policy changes on drug development in developing countries.

Findings

An innovation policy model consists of the relational influences of contextual variables of pharma capabilities, innovation incentives and political factors affecting drug development in developing countries, derived from a dissenting policy-making perspective. This was built to test two hypotheses of a positive relationship between the above variables; and a perspectives gap between the pharmaceutical companies and the policymakers. These hypotheses address issues related to the lack of drug development in developing countries.

Research limitations/implications

This paper presents a conceptual framework for the evaluation and provides examples of its use, but it is currently at a relatively early stage of research. Further work is currently underway and will later be presented to the same journal.

Social implications

Domestic drug development in developing countries needs to be feasible in order to ensure drug security. This predictive policy model provides a comprehensive approach to health policy reforms to examine innovation strategies.

Originality/value

This model includes measures to explore whether pharma capabilities, innovation incentives and/or political factors have an effect on domestic drug development in developing countries. It bridges the policy implementation’s operational process between pharmaceutical companies and policymakers.

Details

International Journal of Health Governance, vol. 24 no. 2
Type: Research Article
ISSN: 2059-4631

Keywords

Access Restricted. View access options
Article
Publication date: 27 March 2020

Ria Christine Siagian, Anhari Achadi, Hasbullah Thabrany, Dumilah Ayuningtyas, Prastuti Soewondo, Sutanto Priyo Hastono, Purnawan Junadi, Novilia Sjafri Bachtiar and Tepy Usia

The pharmaceutical industry in Indonesia appears hesitant to make the transition from inventor to innovator and instead continues with the process of formulation and packaging…

256

Abstract

Purpose

The pharmaceutical industry in Indonesia appears hesitant to make the transition from inventor to innovator and instead continues with the process of formulation and packaging. Evidence-based policy has been advocated for Indonesia and, in general, this is more likely to hold. This study aims to establish a model for a policy-making process that is strategically able to predict strategies that would encourage drug development in Indonesia.

Design/methodology/approach

A quantitative approach with the survey method was designed to obtain appropriate data from a population of pharmaceutical industries in Indonesia and relevant government institutions to assess the relationship of various factors capable of triggering domestic drug development, including pharma capability, political feasibility and innovation incentives. The construct was validated using a set of techniques pertaining to the calculation of structural equation modeling.

Findings

The model demonstrates how it matters when applied to the policy-making process. It proves that pharma capability, political feasibility, and innovation incentives correlated to pharma capability are major catalysts in the promotion of drug development. These are largely explained by market opportunity, pull factors, government power, and position. Although all of the elements were moderately to strongly related to the promotion of drug development, this study has revealed the predictive impact on drug development in Indonesia to be only 46%.

Originality/value

This study adds values to policy-makers as it attempts to predict strategies that would encourage a successful policy when being implemented. Encompassing both pharma industries and government institutions, this study captures a real situation and provides an empirical contribution to the concept of the integrated research of drug development in developing countries.

Details

International Journal of Health Governance, vol. 25 no. 2
Type: Research Article
ISSN: 2059-4631

Keywords

1 – 3 of 3
Per page
102050